The global EEG, EMG and evoked potential devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2021 to 2030. The growth of this market is attributed to the increasing number of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease and multiple sclerosis which are driving the demand for these devices. The increasing awareness about these disorders among people has also led to an increase in demand for these devices.
The global EEG, EMG and evoked potential devices market by type includes electroencephalography (EEG), electromyography (EMG) and evoked potentials. The application segment includes infections, head injuries, coma and brain death, metabolic disorders, cerebrovascular disorders. North America is expected to dominate this market with a share of over 40%.
- The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy is driving the growth of the global EEG, EMG and Evoked Potential Devices market.
- The increasing number of hospitals and clinics that are using these devices for diagnosis purposes is also driving the growth of the global EEG, EMG and Evoked Potential Devices market.
- The growing awareness about these devices among physicians is also a major factor contributing to the growth of this market.
- Increasing government funding for research in this field is another factor contributing to the growth of this market.
- Increasing demand for these devices from emerging economies such as China and India will also drive the growth of this market.
Industry Growth Insights published a new data on “EEG, EMG and Evoked Potential Devices Market”. The research report is titled “EEG, EMG and Evoked Potential Devices Market research by Types (Electroencephalography (EEG), Electromyography (EMG), Evoked Potential), By Applications (Infections, Head Injuries, Coma and Brain Death, Metabolic Disorders, Cerebrovascular Disorders), By Players/Companies Cadwell Laboratories, Inc. (US), Compumedics Limited (Australia), EB Neuro S.P.A. (Italy), Electrical Geodesics, Inc. (US), Lifelines Neurodiagnostic Systems, Inc. (US), Natus Medical Incorporated (US), NeuroWave Systems, Inc. (US), Nihon Kohden Corporation (Japan), Nihon Kohden America, Inc. (US), Noraxon U.S.A., Inc. (US)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
EEG, EMG and Evoked Potential Devices Market Research Report
By Type
Electroencephalography (EEG), Electromyography (EMG), Evoked Potential
By Application
Infections, Head Injuries, Coma and Brain Death, Metabolic Disorders, Cerebrovascular Disorders
By Companies
Cadwell Laboratories, Inc. (US), Compumedics Limited (Australia), EB Neuro S.P.A. (Italy), Electrical Geodesics, Inc. (US), Lifelines Neurodiagnostic Systems, Inc. (US), Natus Medical Incorporated (US), NeuroWave Systems, Inc. (US), Nihon Kohden Corporation (Japan), Nihon Kohden America, Inc. (US), Noraxon U.S.A., Inc. (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global EEG, EMG and Evoked Potential Devices Market Report Segments:
The global EEG, EMG and Evoked Potential Devices market is segmented on the basis of:
Types
Electroencephalography (EEG), Electromyography (EMG), Evoked Potential
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infections, Head Injuries, Coma and Brain Death, Metabolic Disorders, Cerebrovascular Disorders
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cadwell Laboratories, Inc. (US)
- Compumedics Limited (Australia)
- EB Neuro S.P.A. (Italy)
- Electrical Geodesics, Inc. (US)
- Lifelines Neurodiagnostic Systems, Inc. (US)
- Natus Medical Incorporated (US)
- NeuroWave Systems, Inc. (US)
- Nihon Kohden Corporation (Japan)
- Nihon Kohden America, Inc. (US)
- Noraxon U.S.A., Inc. (US)
Highlights of The EEG, EMG and Evoked Potential Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electroencephalography (EEG)
- Electromyography (EMG)
- Evoked Potential
- By Application:
- Infections
- Head Injuries
- Coma and Brain Death
- Metabolic Disorders
- Cerebrovascular Disorders
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the EEG, EMG and Evoked Potential Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
EEG, EMG and Evoked Potential Devices measure the electrical activity of the brain. EEG measures the electrical activity in different parts of the brain while EMG measures muscle movement. Evoked potential devices measure how much a person's nerve cells fire when they are stimulated.
Some of the key players operating in the eeg, emg and evoked potential devices market are Cadwell Laboratories, Inc. (US), Compumedics Limited (Australia), EB Neuro S.P.A. (Italy), Electrical Geodesics, Inc. (US), Lifelines Neurodiagnostic Systems, Inc. (US), Natus Medical Incorporated (US), NeuroWave Systems, Inc. (US), Nihon Kohden Corporation (Japan), Nihon Kohden America, Inc. (US), Noraxon U.S.A., Inc. (US).
The eeg, emg and evoked potential devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. EEG, EMG and Evoked Potential Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. EEG, EMG and Evoked Potential Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. EEG, EMG and Evoked Potential Devices Market - Supply Chain
4.5. Global EEG, EMG and Evoked Potential Devices Market Forecast
4.5.1. EEG, EMG and Evoked Potential Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. EEG, EMG and Evoked Potential Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. EEG, EMG and Evoked Potential Devices Market Absolute $ Opportunity
5. Global EEG, EMG and Evoked Potential Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
5.3.1. Electroencephalography (EEG)
5.3.2. Electromyography (EMG)
5.3.3. Evoked Potential
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global EEG, EMG and Evoked Potential Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
6.3.1. Infections
6.3.2. Head Injuries
6.3.3. Coma and Brain Death
6.3.4. Metabolic Disorders
6.3.5. Cerebrovascular Disorders
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global EEG, EMG and Evoked Potential Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global EEG, EMG and Evoked Potential Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global EEG, EMG and Evoked Potential Devices Demand Share Forecast, 2019-2026
9. North America EEG, EMG and Evoked Potential Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
9.4.1. Infections
9.4.2. Head Injuries
9.4.3. Coma and Brain Death
9.4.4. Metabolic Disorders
9.4.5. Cerebrovascular Disorders
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
9.7.1. Electroencephalography (EEG)
9.7.2. Electromyography (EMG)
9.7.3. Evoked Potential
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America EEG, EMG and Evoked Potential Devices Demand Share Forecast, 2019-2026
10. Latin America EEG, EMG and Evoked Potential Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
10.4.1. Infections
10.4.2. Head Injuries
10.4.3. Coma and Brain Death
10.4.4. Metabolic Disorders
10.4.5. Cerebrovascular Disorders
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
10.7.1. Electroencephalography (EEG)
10.7.2. Electromyography (EMG)
10.7.3. Evoked Potential
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America EEG, EMG and Evoked Potential Devices Demand Share Forecast, 2019-2026
11. Europe EEG, EMG and Evoked Potential Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
11.4.1. Infections
11.4.2. Head Injuries
11.4.3. Coma and Brain Death
11.4.4. Metabolic Disorders
11.4.5. Cerebrovascular Disorders
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
11.7.1. Electroencephalography (EG)
11.7.2. Electromyography (EMG)
11.7.3. Evoked Potential
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe EEG, EMG and Evoked Potential Devices Demand Share, 2019-2026
12. Asia Pacific EEG, EMG and Evoked Potential Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
12.4.1. Infections
12.4.2. Head Injuries
12.4.3. Coma and Brain Death
12.4.4. Metabolic Disorders
12.4.5. Cerebrovascular Disorders
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
12.7.1. Electroencephalography (EEG)
12.7.2. Electromyography (EMG)
12.7.3. Evoked Potential
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific EEG, EMG and Evoked Potential Devices Demand Share, 2019-2026
13. Middle East & Africa EEG, EMG and Evoked Potential Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Application
13.4.1. Infections
13.4.2. Head Injuries
13.4.3. Coma and Brain Death
13.4.4. Metabolic Disorders
13.4.5. Cerebrovascular Disorders
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa EEG, EMG and Evoked Potential Devices Market Size and Volume Forecast by Type
13.7.1. Electroencephalography (EEG)
13.7.2. Electromyography (EMG)
13.7.3. Evoked Potential
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa EEG, EMG and Evoked Potential Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global EEG, EMG and Evoked Potential Devices Market: Market Share Analysis
14.2. EEG, EMG and Evoked Potential Devices Distributors and Customers
14.3. EEG, EMG and Evoked Potential Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cadwell Laboratories, Inc. (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Compumedics Limited (Australia)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. EB Neuro S.P.A. (Italy)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Electrical Geodesics, Inc. (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lifelines Neurodiagnostic Systems, Inc. (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Natus Medical Incorporated (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NeuroWave Systems, Inc. (US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nihon Kohden Corporation (Japan)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Nihon Kohden America, Inc. (US)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Noraxon U.S.A., Inc. (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
